GSK Twinrix Hep A/B Vaccine Comparative Phase IV Safety Study Planned
Executive Summary
GlaxoSmithKline's combination hepatitis A/hepatitis B vaccine Twinrix will be evaluated in a comparative safety study as part of its postmarketing requirements to expand the safety database for the product.